Celgenyx Gene Technology

Company Deals

Celgenyx Completes RMB 100M Series A Financing for Next-Gen Cell Therapy Development

Fineline Cube Oct 25, 2022

China-based Hangzhou Celgenyx Gene Technology Co., Ltd has announced the completion of a Series A...

Company Drug

InnoCare’s Zurletrectinib Wins NMPA Nod as China’s First Next-Gen TRK Inhibitor

Company Deals

Brii Biosciences Taps OpenBench AI Platform to Accelerate Drug Discovery

Company Deals

GSK Terminates Ideaya Synthetic Lethality Partnership, Returns Two Clinical Programs

Company Deals

B&K Corporation Debuts on HKEX in $900M IPO Backed by Burn Drug Pipeline